PS2: Patient experience data – The next steps towards medicines evaluation
By Anna Koptina2024-11-08T06:56:00
Key points:
- Harmonisation is essential: the lack of standardisation across data collection and reporting methods for patient experience data (PED) continues to be a challenge. Greater alignment on methodologies is needed to ensure PED is used effectively in regulatory decisions
- Technological tools like Collaborare are paving the way for better data collection: web-based platforms that facilitate patient engagement in data collection are critical to addressing fragmentation and cultural barriers within patient organisations
To read more key points and the session summary, log in as a member or register for free using the links below.